Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 06/18/2013

Company Name Symbol %Change
STAAR SURGIC STAA
10.98%
DTS INC DTSI
6.89%
ANIKA THERAP ANIK
6.04%
LUMOS NETWOR LMOS
5.70%
INSTEEL IND IIIN
5.28%

Raytheon Gets Stunner Contract

by Zacks Equity Research

January 10, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Raytheon Company (RTN - Analyst Report) has received a contract, worth $30.2 million, for the continuous development of the Stunner interceptor from the Rafael Advanced Defense Systems. Per the contract, the company will manufacture Stunner interceptor’s missile subsystem hardware which also includes safety devices.

Stunner is an advanced, multi-mission, multi-platform interceptor that deliberately integrates into current and planned air and missile defense systems. It has the potential to defeat a variety of short-range ballistic missiles, large caliber rockets and cruise missiles.

Both Raytheon and Rafael had signed an agreement for production and development of the Stunner interceptor in 2009. The first flight tests of the Stunner missile are expected to be conducted in 2012. The company will also arrange for flight tests and low-rate initial production of the Stunner interceptor as per the current contract.

Meanwhile the company is also busy with radar contracts. Recently, the company received two orders to provide AN/TPY-2 radars to the Terminal High Altitude Area Defense (“THAAD”) missile defense system of the U.S. Army and United Arab Emirates (“UAE”).

Raytheon is one of the best-positioned companies among the large-cap defense players. Looking forward, the company enjoys strong order bookings and order backlog, an improving balance sheet, growing cash flow, and operational improvements.

This is, however, offset by apprehensions over future growth of the U.S. defense budget, the fate of high-cost programs, risks related to key project executions and order cancellations. The company presently retains a short-term Zacks #3 Rank (Hold) that corresponds with our long-term Neutral recommendation on the stock.

Raytheon Company is a technology and innovation leader specializing in defense, homeland security and other government markets throughout the world. The company provides state-of-the-art electronics, mission systems integration and other capabilities in the areas of sensing; effects; and command, control, communications and intelligence systems, as well as a broad range of mission support services. Some of its main competitors are Lockheed Martin Corporation (LMT - Analyst Report) and Northrop Grumman Corporation (NOC - Analyst Report).

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.